Logo image of NPW1.DE

SMITH & NEPHEW PLC (NPW1.DE) Stock Price, Forecast & Analysis

Europe - Frankfurt Stock Exchange - FRA:NPW1 - GB0009223206 - Common Stock

14.3 EUR
+0.26 (+1.82%)
Last: 11/24/2025, 7:00:00 PM

NPW1.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap6.06B
Revenue(TTM)5.94B
Net Income(TTM)491.00M
Shares423.90M
Float423.04M
52 Week HighN/A
52 Week LowN/A
Yearly Dividend0.32
Dividend Yield2.33%
EPS(TTM)0.48
PE29.79
Fwd PE12.39
Earnings (Next)02-23 2026-02-23/amc
IPO1951-08-13
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


NPW1.DE short term performance overview.The bars show the price performance of NPW1.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months

NPW1.DE long term performance overview.The bars show the price performance of NPW1.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of NPW1.DE is 14.3 EUR.

SMITH & NEPHEW PLC / NPW1 Daily stock chart

NPW1.DE Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
2M6.DE MEDTRONIC PLC 18.28 114.42B
1MDT.MI MEDTRONIC PLC 18.6 114.29B
SHL.DE SIEMENS HEALTHINEERS AG 17.79 47.97B
PHIA.AS KONINKLIJKE PHILIPS NV 16.23 23.13B
PHI1.DE KONINKLIJKE PHILIPS NV 16.07 22.90B
1PHIA.MI KONINKLIJKE PHILIPS NV 16.3 22.60B
BIM.PA BIOMERIEUX 28.5 13.02B
OBCK.DE OTTOBOCK SE & CO KGAA 160 4.81B
AFX.DE CARL ZEISS MEDITEC AG - BR 26.96 4.12B
DIA.MI DIASORIN SPA 18.27 3.38B
DRW3.DE DRAEGERWERK AG - PREF 10.83 1.31B
DRW8.DE DRAEGERWERK AG 9.46 1.14B

About NPW1.DE

Company Profile

NPW1 logo image Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 17,000 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.

Company Info

SMITH & NEPHEW PLC

Building 5, Croxley Park, Hatters Lane

Watford HERTFORDSHIRE GB

Employees: 17349

NPW1 Company Website

NPW1 Investor Relations

Phone: 4401923477100

SMITH & NEPHEW PLC / NPW1.DE FAQ

What does SMITH & NEPHEW PLC do?

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 17,000 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.


What is the stock price of SMITH & NEPHEW PLC today?

The current stock price of NPW1.DE is 14.3 EUR. The price increased by 1.82% in the last trading session.


What is the dividend status of SMITH & NEPHEW PLC?

SMITH & NEPHEW PLC (NPW1.DE) has a dividend yield of 2.33%. The yearly dividend amount is currently 0.32.


How is the ChartMill rating for SMITH & NEPHEW PLC?

NPW1.DE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What is the GICS sector and industry of NPW1 stock?

SMITH & NEPHEW PLC (NPW1.DE) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


What is the employee count for NPW1 stock?

SMITH & NEPHEW PLC (NPW1.DE) currently has 17349 employees.


When does SMITH & NEPHEW PLC (NPW1.DE) report earnings?

SMITH & NEPHEW PLC (NPW1.DE) will report earnings on 2026-02-23, after the market close.


NPW1.DE Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to NPW1.DE.


Chartmill TA Rating
Chartmill Setup Rating

NPW1.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to NPW1.DE. NPW1.DE has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NPW1.DE Financial Highlights

Over the last trailing twelve months NPW1.DE reported a non-GAAP Earnings per Share(EPS) of 0.48. The EPS increased by 59.86% compared to the year before.


Industry RankSector Rank
PM (TTM) 8.26%
ROA 4.59%
ROE 8.87%
Debt/Equity 0.6
Chartmill High Growth Momentum
EPS Q2Q%35.92%
Sales Q2Q%4.74%
EPS 1Y (TTM)59.86%
Revenue 1Y (TTM)5.35%

NPW1.DE Forecast & Estimates

23 analysts have analysed NPW1.DE and the average price target is 16.86 EUR. This implies a price increase of 17.9% is expected in the next year compared to the current price of 14.3.

For the next year, analysts expect an EPS growth of 28.32% and a revenue growth 6.38% for NPW1.DE


Analysts
Analysts76.52
Price Target16.86 (17.9%)
EPS Next Y28.32%
Revenue Next Year6.38%

NPW1.DE Ownership

Ownership
Inst Owners73.82%
Ins Owners0.12%
Short Float %N/A
Short RatioN/A